Abiopharma

🔍 Miskel Christopher C. (Director)

Company: Arthur J. Gallagher & Co. (AJG)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 153 shares of Common Stock at $262.0 per share (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,826.44 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This acquisition resulted from the reporting person's election in a prior year (pursuant to the Company's Director Deferral Plan) to defer the reporting person's annual cash retainer, which the Company pays on a quarterly basis, into deferred share units that will be distributed in the form of the Company's common stock.